Studies conducted by Akkari L and colleagues identified GAM gene expression signatures of different stages after radiotherapy in murine gliomas and found that targeting GAM populations using a colony-stimulating factor-1 receptor (CSF-1R) inhibitor combined with radiotherapy substantially enhanced survival in preclinical models [54]. The gene discussed is CSF1R; the disease is central nervous system cancer.